Resources from the same session
LBA2 - Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up of the East Asian subgroup of the randomized phase III LITESPARK-005 trial
Presenter: Jae-Lyun Lee
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
268O - Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
Presenter: Liangyou Gu
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA2 and 268O
Presenter: Wei Chong Tan
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session: Genitourinary tumours
Resources:
Webcast
269O - Enfortumab vedotin plus pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Pan-Asian subgroup analysis from EV-302/KEYNOTE-A39
Presenter: Eiji Kikuchi
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
270O - Nivolumab (NIVO) plus gemcitabine-cisplatin (GC) vs GC alone in Asian patients with previously untreated unresectable or metastatic urothelial carcinoma (u/mUC) from CheckMate 901
Presenter: Yoshihiko Tomita
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
271O - Interim analysis (IA) of SPADE: A prospective, real-world study of avelumab first-line maintenance (1LM) treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Asia-Pacific (APAC) region
Presenter: Jungmin Jo
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
LBA9 - TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety analysis
Presenter: Petros Grivas
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 269O, 270O, 271O and LBA9
Presenter: Terence Friedlander
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast